Skip to main content
Top
Published in: memo - Magazine of European Medical Oncology 2/2019

Open Access 01-06-2019 | Smoking and Nicotine Detoxification | short review

Tobacco control: prevention and cessation in Europe

Author: Prof. Manfred Neuberger

Published in: memo - Magazine of European Medical Oncology | Issue 2/2019

Login to get access

Summary

Reasons for high smoking prevalence in Europe compared to Australia and North America are low prices of tobacco adjusted for purchasing power and poor smoke-free legislation and enforcement in Central and Eastern Europe. High rates of passive smoking in Czechia, Slovakia, Poland and Austria are associated with weak implementation of smoke-free public rooms, especially in the hospitality industry. In 2018 Austria cancelled the smoking ban in all bars and restaurants and continued to allow access to minors, while Hungary since 2012 showed remarkable success by limiting supply of cigarettes and by banning access of minors to tobacco shops. Even more advanced are Western European countries because of lower affordability of cigarettes, ban of smoking rooms and tobacco advertising, plain packaging and public information campaigns. Smoking cessation services across Europe make use of quitlines, provide internet counseling and apps for self-help. Cooperation with physicians should be improved and could help oncologists to combine cancer screening with smoking cessation. Cancer therapy is more successful after smoking cessation.
Literature
4.
go back to reference Chen Z, Peto R, Zhou M, et al. Contrasting male and female trends in tobacco-attributed mortality in China: Evidence from successive nationwide prospective cohort studies. Lancet. 2015;386:1447–56.CrossRef Chen Z, Peto R, Zhou M, et al. Contrasting male and female trends in tobacco-attributed mortality in China: Evidence from successive nationwide prospective cohort studies. Lancet. 2015;386:1447–56.CrossRef
15.
go back to reference Gallus S, Schiaffino A, La Vecchia C, et al. Price and cigarette consumption in Europe. Tob Control. 2006;15(2):114–9.CrossRef Gallus S, Schiaffino A, La Vecchia C, et al. Price and cigarette consumption in Europe. Tob Control. 2006;15(2):114–9.CrossRef
21.
go back to reference Horak F, Fazekas T, Zacharasiewicz A, et al. The fetal tobacco syndrome. Wien Klin Wochenschr. 2012;124(5–6):129–45. A statement of the Austrian Societies for General- and Family Medicine (OGAM), Gynecology and Obstetrics (OGGG), Hygiene, Microbiology and Preventive Medicine (OGHMP), Pediatrics and Adolescence Medicine (OGKJ) as well as Pneumology (OGP).CrossRef Horak F, Fazekas T, Zacharasiewicz A, et al. The fetal tobacco syndrome. Wien Klin Wochenschr. 2012;124(5–6):129–45. A statement of the Austrian Societies for General- and Family Medicine (OGAM), Gynecology and Obstetrics (OGGG), Hygiene, Microbiology and Preventive Medicine (OGHMP), Pediatrics and Adolescence Medicine (OGKJ) as well as Pneumology (OGP).CrossRef
22.
go back to reference Moshammer H, Hoek G, Luttmann-Gibson H, et al. Parental smoking and lung function in children. An international study. Am J Respir Crit Care Med. 2006;173:1255–63.CrossRef Moshammer H, Hoek G, Luttmann-Gibson H, et al. Parental smoking and lung function in children. An international study. Am J Respir Crit Care Med. 2006;173:1255–63.CrossRef
23.
go back to reference Muttarak R, Steiber N, Gallus S. Smoking ban in Austria: A long overdue step but still a lot to be done. Lancet. 2015;385(9972):941–2.CrossRef Muttarak R, Steiber N, Gallus S. Smoking ban in Austria: A long overdue step but still a lot to be done. Lancet. 2015;385(9972):941–2.CrossRef
27.
go back to reference Hutter HP, Moshammer H, Neuberger M. Smoking cessation at the workplace: One year success of short seminars. Int Arch Occup Environ Health. 2006;79:42–8.CrossRef Hutter HP, Moshammer H, Neuberger M. Smoking cessation at the workplace: One year success of short seminars. Int Arch Occup Environ Health. 2006;79:42–8.CrossRef
28.
go back to reference Moshammer H, Neuberger M. Long term success of short smoking cessation seminars supported by occupational health care. Addict Behav. 2007;32(7):1486–93.CrossRef Moshammer H, Neuberger M. Long term success of short smoking cessation seminars supported by occupational health care. Addict Behav. 2007;32(7):1486–93.CrossRef
31.
go back to reference Tao L, Wang R, Gao YT, Yuan JM. Impact of postdiagnosis smoking on long-term survival of cancer patients: The Shanghai cohort study. Cancer Epidemiol Biomarkers Prev. 2013;22(12):2404–11.CrossRef Tao L, Wang R, Gao YT, Yuan JM. Impact of postdiagnosis smoking on long-term survival of cancer patients: The Shanghai cohort study. Cancer Epidemiol Biomarkers Prev. 2013;22(12):2404–11.CrossRef
33.
go back to reference Dobson Amato KA, Hyland A, Reed R. Tobacco cessation May improve lung cancer patient survival. J Thorac Oncol. 2015;10(7):1014–9.CrossRef Dobson Amato KA, Hyland A, Reed R. Tobacco cessation May improve lung cancer patient survival. J Thorac Oncol. 2015;10(7):1014–9.CrossRef
Metadata
Title
Tobacco control: prevention and cessation in Europe
Author
Prof. Manfred Neuberger
Publication date
01-06-2019
Publisher
Springer Vienna
Published in
memo - Magazine of European Medical Oncology / Issue 2/2019
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-0485-6

Other articles of this Issue 2/2019

memo - Magazine of European Medical Oncology 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine